← Back
Data updated: Mar 10, 2026
PURACAP PHARM
Immunology
PURACAP PHARM is a generic drug manufacturer focused on Immunology.
1974
Since
13
Drugs
-
Trials
143
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
AMLODIPINE BESYLATE 2026-02-17
Manufacturing (CMC)
AMLODIPINE BESYLATE 2026-01-26
Manufacturing (CMC)
NAPROXEN SODIUM 2026-01-24
Labeling
NAPROXEN SODIUM 2026-01-24
Labeling
NAPROXEN SODIUM 2026-01-24
Labeling
AMLODIPINE BESYLATE 2026-01-22
NAPROXEN SODIUM 2026-01-15
Labeling
ACETAMINOPHEN AND CODEINE PHOSPHATE 2025-12-22
Labeling
ACETAMINOPHEN AND CODEINE PHOSPHATE 2025-12-22
Labeling
ACETAMINOPHEN AND CODEINE PHOSPHATE 2025-12-22
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Immunology 100%
1 drugs
Pipeline Strength Pro
Loading...
Discontinued (9)
Company Info
- First Approval
- 1974-10-22
- Latest
- 2024-12-16
- Applications
- 15
FDA Sponsor Names
PURACAP PHARMPURACAP PHARM LLC